Skip to main content

GOLDMAN SACHS GROUP INC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in ATNM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$69,889
-$25,797 QoQ
Shares Held
70,241
-0.2% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ATNM ranks #348 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATNM

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $69,889 70,241
2025-12-31 $95,686 70,358
2025-06-30 $127,975 91,411
2025-03-31 $123,664 76,811
2024-12-31 $170,472 135,296
2024-09-30 $171,817 91,393
2024-06-30 $298,056 40,278
2024-03-31 $87,281 11,147
2023-12-31 $78,638 15,480
2023-09-30 $274,356 46,344
2023-06-30 $103,427 13,939
2023-03-31 $879,936 93,115
2022-12-31 $107,458 10,090
2022-09-30 $74,205 10,055